Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ri Liesner

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Research and Practice in Thrombosis and Haemostasis|July 15, 2021
Plasma-derived factor X concentrate compassionate use for hereditary factor X deficiency: Long-term safety and efficacy in a retrospective data-collection studyJames N Huang, Ri Liesner, Steven K Austin, et al.
Journal of Clinical Pathology|November 27, 2014
The value of the white precursor cell channel (WPC) on the Sysmex XN-1000 analyser in a specialist paediatric hospitalAmanda S Jones, Hitesh Tailor, Ri Liesner, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 23, 2006
Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist deviceOlivier Ghez, Ri Liesner, Ann Karimova, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 20, 2010
Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assaysVickie McDonald, Ri Liesner, John Grainger, et al.
British Journal of Haematology|February 18, 2003
Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapyPhil J Ancliff, Rosemary E Gale, Ri Liesner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 4, 2018
Genotype analysis and identification of novel mutations in a multicentre cohort of patients with hereditary factor X deficiencyMichael Mitchell, Michael Gattens, Kaan Kavakli, et al.
The Journal of Clinical Investigation|January 4, 2003
A novel form of integrin dysfunction involving beta1, beta2, and beta3 integrinsAlison McDowall, David Inwald, Birgit Leitinger, et al.
British Journal of Haematology|July 28, 2011
Guidelines for the laboratory investigation of heritable disorders of platelet functionPaul Harrison, Ian Mackie, Andrew Mumford, et al.
British Journal of Haematology|May 21, 2011
Guideline on the investigation, management and prevention of venous thrombosis in childrenElizabeth Chalmers, Vijeya Ganesen, Ri Liesner, et al.
British Journal of Haematology|March 17, 2010
A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia AMichael Richards, Michael Williams, Elizabeth Chalmers, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Research and Practice in Thrombosis and Haemostasis|July 15, 2021
Plasma-derived factor X concentrate compassionate use for hereditary factor X deficiency: Long-term safety and efficacy in a retrospective data-collection studyJames N Huang, Ri Liesner, Steven K Austin, et al.
Journal of Clinical Pathology|November 27, 2014
The value of the white precursor cell channel (WPC) on the Sysmex XN-1000 analyser in a specialist paediatric hospitalAmanda S Jones, Hitesh Tailor, Ri Liesner, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 23, 2006
Subcutaneous low molecular weight heparin for management of anticoagulation in infants on excor ventricular assist deviceOlivier Ghez, Ri Liesner, Ann Karimova, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 20, 2010
Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assaysVickie McDonald, Ri Liesner, John Grainger, et al.
British Journal of Haematology|February 18, 2003
Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapyPhil J Ancliff, Rosemary E Gale, Ri Liesner, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 4, 2018
Genotype analysis and identification of novel mutations in a multicentre cohort of patients with hereditary factor X deficiencyMichael Mitchell, Michael Gattens, Kaan Kavakli, et al.
The Journal of Clinical Investigation|January 4, 2003
A novel form of integrin dysfunction involving beta1, beta2, and beta3 integrinsAlison McDowall, David Inwald, Birgit Leitinger, et al.
British Journal of Haematology|July 28, 2011
Guidelines for the laboratory investigation of heritable disorders of platelet functionPaul Harrison, Ian Mackie, Andrew Mumford, et al.
British Journal of Haematology|May 21, 2011
Guideline on the investigation, management and prevention of venous thrombosis in childrenElizabeth Chalmers, Vijeya Ganesen, Ri Liesner, et al.
British Journal of Haematology|March 17, 2010
A United Kingdom Haemophilia Centre Doctors' Organization guideline approved by the British Committee for Standards in Haematology: guideline on the use of prophylactic factor VIII concentrate in children and adults with severe haemophilia AMichael Richards, Michael Williams, Elizabeth Chalmers, et al.
Pageof 6